P2Y(1) Receptor Activation Inhibits NMDA Receptor-channels in Layer V Pyramidal Neurons of the Rat Prefrontal and Parietal Cortex
Overview
Authors
Affiliations
In the 1st part of this study, monosynaptic excitatory postsynaptic potentials (EPSPs) in layer V of the rat prefrontal cortex (PFC) were evoked by electrical stimulation of layer I. Recordings with intracellular sharp, microelectrodes showed a concentration-dependent inhibition of the EPSP by adenosine 5'-O-(2-thiodiphosphate) (ADP-beta-S). Pyridoxal-phosphate-6-azophenyl-2',4'-disulphonic acid (PPADS), when given alone depressed the EPSP and in addition antagonized the effect of ADP-beta-S. Exclusion of the N-methyl-D-aspartate (NMDA) component of the EPSP by D(.)-amino-5-phosphonopentanoic acid (AP-5) abolished the ADP-beta-S-induced depression. The pressure-application of both NMDA and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) caused reproducible depolarizations. ADP-beta-S inhibited the effect of NMDA, but did not alter that of AMPA. PPADS was also under these conditions antagonistic with ADP-beta-S. In the 2nd part of the study, NMDA-induced currents were measured by whole-cell patch-clamp pipettes. ADP-beta-S caused a concentration-dependent inhibition of the responses to NMDA. PPADS alone did not alter the NMDA-currents but again antagonized the action of ADP-beta-S; 2'-deoxy-N(6)-methyladenosine-3',5'-diphosphate (MRS 2179) also abolished the NMDA effect. The ADP-beta-S-induced inhibition persisted in the presence of tetrodotoxin (TTX) or guanosine 5'-O-(3-thiodiphosphate) (GDP-beta-S) applied to the external medium and the pipette solution, respectively. The 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) moderately decreased the ADP-beta-S effect. The inhibitory function of ADP-beta-S on EPSPs and the interaction with PPADS was observed also in layer V pyramidal neurons of the parietal somatosensory cortex. In conclusion, metabotropic P2Y(1) receptors appear to exert a new modulatory influence on fast excitatory amino acid transmission in the cerebral cortex.
Hanuska A, Ribiczey P, Kato E, Papp Z, Varga Z, Giricz Z Int J Mol Sci. 2024; 25(23).
PMID: 39684355 PMC: 11641273. DOI: 10.3390/ijms252312644.
P2Y1 Receptor as a Catalyst of Brain Neurodegeneration.
Rodrigues R, Figueira A, Marques J NeuroSci. 2024; 3(4):604-615.
PMID: 39483765 PMC: 11523754. DOI: 10.3390/neurosci3040043.
Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease.
Juvenal G, Higa G, Bonfim Marques L, Tessari Zampieri T, Viana F, Britto L Purinergic Signal. 2024; .
PMID: 39046648 DOI: 10.1007/s11302-024-10034-x.
Chen Y, Rindner D, Fowler J, Lallai V, Mogul A, Demuro A J Neurosci. 2023; 43(48):8259-8270.
PMID: 37821229 PMC: 10697394. DOI: 10.1523/JNEUROSCI.1290-23.2023.
Quintas C, Goncalves J, Queiroz G Cells. 2023; 12(13).
PMID: 37443726 PMC: 10341078. DOI: 10.3390/cells12131690.